| Literature DB >> 36188120 |
Yushan Zhang1,2, Chandra Kumar Elechalawar1,2, Wen Yang3, Alex N Frickenstein3, Sima Asfa1,2, Kar-Ming Fung1,2, Brennah N Murphy1,2, Shailendra K Dwivedi2,4, Geeta Rao1,2, Anindya Dey2,4, Stefan Wilhelm2,3,5, Resham Bhattacharya2,4, Priyabrata Mukherjee1,2.
Abstract
The tumor microenvironment (TME) plays a key role in the poor prognosis of many cancers. However, there is a knowledge gap concerning how multicellular communication among the critical players within the TME contributes to such poor outcomes. Using epithelial ovarian cancer (EOC) as a model, we show how crosstalk among cancer cells (CC), cancer associated fibroblasts (CAF), and endothelial cells (EC) promotes EOC growth. We demonstrate here that co-culturing CC with CAF and EC promotes CC proliferation, migration, and invasion in vitro and that co-implantation of the three cell types facilitates tumor growth in vivo. We further demonstrate that disruption of this multicellular crosstalk using a gold nanoparticle (GNP) inhibits these pro-tumorigenic phenotypes in vitro as well as tumor growth in vivo. Mechanistically, GNP treatment reduces expression of several tumor-promoting cytokines and growth factors, resulting in inhibition of MAPK and PI3K-AKT activation and epithelial-mesenchymal transition - three key oncogenic signaling pathways responsible for the aggressiveness of EOC. The current work highlights the importance of multicellular crosstalk within the TME and its role for the aggressive nature of EOC, and demonstrates the disruption of these multicellular communications by self-therapeutic GNP, thus providing new avenues to interrogate the crosstalk and identify key perpetrators responsible for poor prognosis of this intractable malignancy.Entities:
Keywords: Cancer-associated fibroblast (CAF); Epithelial ovarian cancer (EOC); Epithelial-mesenchymal transition (EMT); Gold nanoparticle (GNP, AuNP); Tumor microenvironment (TME)
Year: 2022 PMID: 36188120 PMCID: PMC9523457 DOI: 10.1016/j.mattod.2022.01.025
Source DB: PubMed Journal: Mater Today (Kidlington) ISSN: 1369-7021 Impact factor: 26.943